Welcome Guest.
Not a member yet? Why not sign up today and start posting on our forums.
Coherus prices biosimilar to Amgen's Neulasta at 33 percent discount
#1

Coherus prices biosimilar to Amgen's Neulasta at 33 percent discount

Coherus BioSciences Inc said on Thursday it would price its biosimilar to Amgen Inc's infection-fighting treatment, Neulasta, at a 33 percent discount.




http://feeds.reuters.com/~r/reuters/heal...SKCN1ND36Q
Reply